Page last updated: 2024-09-03

ginsenoside rh2 and levofloxacin

ginsenoside rh2 has been researched along with levofloxacin in 1 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(levofloxacin)
Trials
(levofloxacin)
Recent Studies (post-2010) (levofloxacin)
29512004,3465812,209

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)levofloxacin (IC50)
Replicase polyprotein 1abBetacoronavirus England 17.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, XY; Hao, K; Liu, Y; Qian, F; Sun, Y; Wang, GJ; Wang, YY; Zha, WB; Zhang, JW; Zhou, F1

Other Studies

1 other study(ies) available for ginsenoside rh2 and levofloxacin

ArticleYear
Ginsenoside 20(S)-Rh2 promotes cellular pharmacokinetics and intracellular antibacterial activity of levofloxacin against Staphylococcus aureus through drug efflux inhibition and subcellular stabilization.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Stability; Female; Ginsenosides; Humans; Intracellular Fluid; Levofloxacin; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcus aureus; Subcellular Fractions; THP-1 Cells

2021